Return to homepagePandemic Pact

Experiences of Opioid Treatment Programs in Delivering Telemedicine Services During the COVID-19 Pandemic

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020
    2020

  • Known Financial Commitments (USD)

    $61,098

  • Funder

    FORE

  • Principal Investigator

    PhD. Sarah Hunter

  • Research Location

    United States of America

  • Lead Research Institution

    RAND Corporation

  • Research Priority Alignment

    N/A

  • Research Category

    Secondary impacts of disease, response & control measures

  • Research Subcategory

    Indirect health impacts

  • Special Interest Tags

    Digital Health

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Due to the COVID-19 pandemic, many opioid treatment programs (OTP) have had to rapidly transition from in-person care to telemedicine. Researchers at RAND will be conducting a qualitative study to explore providers' experiences, the different modalities being offered, barriers encountered, and future plans. The study's findings will inform the ongoing COVID-19 response and elicit lessons learned and policy recommendations for the future of OUD treatment.